Home » Former CMO Brian Levy Sits in the CEO Chair to Lead OcuNexus Down a Bold, New Biopharma Path

Former CMO Brian Levy Sits in the CEO Chair to Lead OcuNexus Down a Bold, New Biopharma Path

Former CMO Brian Levy Sits in the CEO Chair to Lead OcuNexus Down a Bold, New Biopharma Path

Episode 210

Former Aerie CMO Brian Levy, OD, was settling down for a quieter life in Florida when he came upon OcuNexus, a biopharmaceutical company utilizing a novel mechanism of action called “Gap Junction Channel Modulation” to develop treatments for the front and back of the eye. Levy saw the opportunity to create a biopharma capable of devising new therapies inside and outside of ophthalmology.

Do You Have

A STORY TO TELL?

If you’d like to be considered as a guest on a future episode of the OIS podcast, please complete the application today.

Meet Our Host

TOM SALEMI

Tom-Salemi

Joining the company in 2014, to create and manage a new line of podcasts, publications and other editorial products.

Subscribe

ON iTUNES

Don't miss an episode. Join the conversation by visiting our podcast channel on iTunes today and subscribe. It's fast and free!

STAY UP TO DATE WITH OIS

Get the Latest News, Podcasts and Videos.